These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 9555070
1. Changes in presynaptic protein NACP/alpha-synuclein in an ischemic gerbil hippocampus. Ishimaru H, Uéda K, Takahashi A, Maruyama Y. Brain Res; 1998 Mar 30; 788(1-2):311-4. PubMed ID: 9555070 [Abstract] [Full Text] [Related]
2. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Sisk A, Masliah E. Lab Invest; 1998 Sep 30; 78(9):1169-77. PubMed ID: 9759660 [Abstract] [Full Text] [Related]
3. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E. Am J Pathol; 1998 Feb 30; 152(2):367-72. PubMed ID: 9466562 [Abstract] [Full Text] [Related]
4. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H. Neurosci Lett; 1997 Dec 12; 239(1):45-8. PubMed ID: 9547168 [Abstract] [Full Text] [Related]
5. Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies. Wakabayashi K, Yoshimoto M, Fukushima T, Koide R, Horikawa Y, Morita T, Takahashi H. Neuropathol Appl Neurobiol; 1999 Oct 12; 25(5):363-8. PubMed ID: 10564525 [Abstract] [Full Text] [Related]
6. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease. Iwai A. Biochim Biophys Acta; 2000 Jul 26; 1502(1):95-109. PubMed ID: 10899435 [Abstract] [Full Text] [Related]
7. Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development. Hsu LJ, Mallory M, Xia Y, Veinbergs I, Hashimoto M, Yoshimoto M, Thal LJ, Saitoh T, Masliah E. J Neurochem; 1998 Jul 26; 71(1):338-44. PubMed ID: 9648883 [Abstract] [Full Text] [Related]
8. Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. Irizarry MC, Kim TW, McNamara M, Tanzi RE, George JM, Clayton DF, Hyman BT. J Neuropathol Exp Neurol; 1996 Aug 26; 55(8):889-95. PubMed ID: 8759778 [Abstract] [Full Text] [Related]
10. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Hashimoto M, Hsu LJ, Xia Y, Takeda A, Sisk A, Sundsmo M, Masliah E. Neuroreport; 1999 Mar 17; 10(4):717-21. PubMed ID: 10208537 [Abstract] [Full Text] [Related]
11. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. Masliah E, Iwai A, Mallory M, Uéda K, Saitoh T. Am J Pathol; 1996 Jan 17; 148(1):201-10. PubMed ID: 8546207 [Abstract] [Full Text] [Related]
17. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. Murphy DD, Rueter SM, Trojanowski JQ, Lee VM. J Neurosci; 2000 May 01; 20(9):3214-20. PubMed ID: 10777786 [Abstract] [Full Text] [Related]